Abiopharma

ARCADIA BIOSCIENCES, INC. (RKDA) Reports the reporting period Financial Results ARCADIA BIOSCIENCES, INC. (RKDA) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 901
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: $315,000,
  • - Zola® revenues increase 17% year
  • - Arcadia and Roosevelt Resources terminate proposed business combination
  • - Exercise of preferred investment options yields $
    • anticipated by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risks set forth in filings that the company makes with the Securities and Exchange Commission from time to time, including in Arcadia’s Annual Report on Form 10-K for the year ended December 31, 2025